Treatment of hypertension in patients with peripheral arterial disease: An update

被引：0
作者：
Denis L. Clement
机构：
[1] Ghent University Hospital,Department of the Dean
来源：
Current Hypertension Reports | 2009年 / 11卷
关键词：
Valsartan; Aliskiren; Intermittent Claudication; Moxonidine; Intermittent Claudication;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Hypertension is a known risk factor for cardiovascular events, and recent data have pointed to peripheral arterial disease (PAD) as another strong risk factor; together, they cause a surprisingly high total risk. This review deals with the clinical management of this dangerous association. The ankle-brachial index helps in the diagnosis of PAD and the estimation of risk. To control risk, lifestyle adaptation is essential. There is no consensus on a first choice of antihypertensive drug. Arguments favor angiotensin-converting enzyme inhibitors, but most patients require several antihypertensive drugs to reach goal pressure (140/90 mm Hg or lower). Moreover, to control the risk of PAD, antiplatelet drugs, antihypertensive drugs, and statins are recommended.
引用
收藏
页码：271 / 276
页数：5
相关论文
共 99 条
[1]  
De Buyzere M.(2008)Management of hypertension in peripheral arterial disease Progress Cardiovasc Dis 50 238-263
[2]  
Clement D.L.(2007)How to treat hypertension in patients with peripheral artery disease Curr Hypertens Rep 9 190-195
[3]  
Clement D.L.(2007)Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 S5-67
[4]  
De Buyzere M.(2007)Diagnosis and treatment of peripheral arterial disease Acta Chir Belg 107 595-604
[5]  
Norgren L.(2007)2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 1105-1187
[6]  
Hiatt W.R.(1992)Natural history and evolution of peripheral obstructive arterial disease Int Angiol 11 165-168
[7]  
Dormandy J.A.(2005)Temporal trends in the incidence of intermittent claudication from 1950 to 1999 Am J Epidemiol 162 430-437
[8]  
Clement D.L.(2000)Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC) J Vasc Surg 31 S1-S296
[9]  
Mancia G.(2006)International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 180-189
[10]  
De Backer G.(2007)One-year cardiovascular event rates in outpatients with atherothrombosis JAMA 297 1197-1206
12345678910